Structure |
Chemical Name |
CAS |
MF |
![Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]-](/CAS/20200611/GIF/298197-26-9.gif) |
Acetamide, N-[9-[[2-(acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-6,9-dihydro-6-oxo-1H-purin-2-yl]- |
298197-26-9 |
C13 H17 N5 O6 |
![Topiroxostat Impurity 46](/) |
Topiroxostat Impurity 46 |
|
|
![Topiroxostat Impurity 43](/) |
Topiroxostat Impurity 43 |
|
|
![N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide](/CAS/20210111/GIF/1643948-40-6.gif) |
N-(2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethyl)-N-methyl formamide |
1643948-40-6 |
C17H25NO3 |
![Regorafenib Impurity 40](/) |
Regorafenib Impurity 40 |
|
|
![3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester](/CAS/20210111/GIF/2489671-14-7.gif) |
3-Quinolinecarboxylic acid, 1-cyclopropyl-7-fluoro-1,4-dihydro-6,8-dimethoxy-4-oxo-, ethyl ester |
2489671-14-7 |
C17H18FNO5 |
![Bisoprolol Impurity 17](/CAS/20210111/GIF/109791-19-7.gif) |
Bisoprolol Impurity 17 |
109791-19-7 |
C15H23NO5 |
![Furosemide Impurity 5](/CAS/20210111/GIF/518336-22-6.gif) |
Furosemide Impurity 5 |
518336-22-6 |
C12H10ClNO3 |
![Lumateperone Impurity 2](/CAS/20210111/GIF/313544-32-0.gif) |
Lumateperone Impurity 2 |
313544-32-0 |
C16H19N3O3 |
![Pramipexole Impurity 55](/CAS/20210111/GIF/959012-83-0.gif) |
Pramipexole Impurity 55 |
959012-83-0 |
C8H11NO2 |
![INDEX NAME NOT YET ASSIGNED](/CAS/20211123/GIF/2438857-80-6.gif) |
INDEX NAME NOT YET ASSIGNED |
2438857-80-6 |
C27H22F2N6O5 |
![Nicergoline Impurity 01](/) |
Nicergoline Impurity 01 |
|
|
![impurity 38](/) |
impurity 38 |
|
|
![Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]-](/CAS/20200611/GIF/2227126-09-0.gif) |
Benzonitrile, 4-[3-[(acetyloxy)methyl]-4-bromophenoxy]- |
2227126-09-0 |
C16H12BrNO3 |
![3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI)](/CAS/20210305/GIF/18206-80-9.gif) |
3-Pyridineacrylonitrile, α-(m-chlorophenyl)-β-hydroxy- (8CI) |
18206-80-9 |
C14H9ClN2O |
![Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI)](/CAS/20211123/GIF/103088-58-0.gif) |
Androsta-3,16-dien-17-ol, acetate, (5α)- (9CI) |
103088-58-0 |
C21H30O2 |
![1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)-](/CAS/20210111/GIF/91797-61-4.gif) |
1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1S,4S)- |
91797-61-4 |
C17H19N |
![2-Pyridineethanamine, N-methyl-N-nitroso-](/CAS/20210111/GIF/32635-81-7.gif) |
2-Pyridineethanamine, N-methyl-N-nitroso- |
32635-81-7 |
C8H11N3O |
![Peramivir Impurity 45](/) |
Peramivir Impurity 45 |
|
|
![Pentanamide, 5-(diphenylphosphinyl)-N-ethyl-](/CAS/20210111/GIF/2512198-63-7.gif) |
Pentanamide, 5-(diphenylphosphinyl)-N-ethyl- |
2512198-63-7 |
C19H24NO2P |
![1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)-](/CAS/20210111/GIF/313369-17-4.gif) |
1H-Pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylic acid, 2,3,6b,9,10,10a-hexahydro-, ethyl ester, (6bR,10aS)- |
313369-17-4 |
C16H21N3O2 |
![Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)-](/CAS/20211123/GIF/57935-66-7.gif) |
Ergoline-8-methanol, 10-hydroxy-1,6-dimethyl-, 8-(5-bromo-3-pyridinecarboxylate), (8β)- |
57935-66-7 |
C23H24BrN3O3 |
![(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide](/) |
(5S,6S,7S)-7-(2-(1H-tetrazol-1-yl)acetamido)-3-(((5-methyl-1,3,4- thiadiazol-2-yl)thio)methyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2- ene-2-carboxylic acid 5-oxide |
|
|
![Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]-](/CAS/20210111/GIF/871266-45-4.gif) |
Ethanone, 2-chloro-1-[3-nitro-4-(phenylmethoxy)phenyl]- |
871266-45-4 |
C15H12ClNO4 |
![Cisatracurium besylate impurity11](/) |
Cisatracurium besylate impurity11 |
|
|
![(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate](/) |
(3R,5S,E)-tert-butyl 7-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methyl methylsulfonamido)pyrimidin-5-yl)-3,5-dihydroxyhept-6-enoate |
|
|
![Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?-](/CAS/20211123/GIF/2575516-61-7.gif) |
Acetamide, N-?[4-?[5-?(acetylamino)?-?2-?hydroxyphenoxy]?phenyl]?- |
2575516-61-7 |
C16H16N2O4 |
![Ganciclovir EP Impurity](/) |
Ganciclovir EP Impurity |
|
|
![Crisaborole Impurity 15](/) |
Crisaborole Impurity 15 |
|
|
![Latamoxef impurity A](/) |
Latamoxef impurity A |
|
|
![(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate](/) |
(E)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate |
|
|
![1-(2-Fluor[1,1'-biphenyl]-4-yl)ethan-1-on](/CAS/GIF/42771-79-9.gif) |
1-(2-Fluor[1,1'-biphenyl]-4-yl)ethan-1-on |
42771-79-9 |
C14H11FO |
![m-Xylol-4,α,α'-triol](/CAS/GIF/2937-60-2.gif) |
m-Xylol-4,α,α'-triol |
2937-60-2 |
C8H10O3 |
![Oseltamivir Impurity 107](/) |
Oseltamivir Impurity 107 |
|
|
![Oseltamivir Impurity 66](/) |
Oseltamivir Impurity 66 |
|
|
![Dapagliflozin Impurity 46](/) |
Dapagliflozin Impurity 46 |
|
|
![Brexpiprazole Impurity ABCDEFGHJKL](/) |
Brexpiprazole Impurity ABCDEFGHJKL |
|
|
![p,p'-(2-Pyridylmethylen)bisphenol](/CAS/GIF/603-41-8.gif) |
p,p'-(2-Pyridylmethylen)bisphenol |
603-41-8 |
C18H15NO2 |
![Tazobactam Impurity DBT](/) |
Tazobactam Impurity DBT |
|
|
![Diginatin](/CAS/20180808/GIF/52589-12-5.gif) |
Diginatin |
52589-12-5 |
C41H64O15 |
![Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]-](/CAS/20210305/GIF/2436275-33-9.gif) |
Thiophene, 2-(2-fluorophenyl)-5-[(5-iodo-2-methylphenyl)methyl]- |
2436275-33-9 |
C18H14FIS |
![Revefenacin Impurity 2](/CAS/20210305/GIF/1158699-78-5.gif) |
Revefenacin Impurity 2 |
1158699-78-5 |
C14H17NO4 |
![(R)-2-(4-Methoxyphenyl)-1-methylethanamine](/CAS/GIF/58993-79-6.gif) |
(R)-2-(4-Methoxyphenyl)-1-methylethanamine |
58993-79-6 |
C10H15NO |
![N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide](/CAS/20210305/GIF/2514947-17-0.gif) |
N-[5-[(1RS)-2-[benzyl[(1RS)-2-(4-methoxyphenyl)- 1-methylethyl]amino]-1-hydroxyethyl]-2- hydroxyphenyl]formamide |
2514947-17-0 |
C26H30N2O4 |
![NA](/) |
NA |
|
|
![Cilastatin Impurity H](/) |
Cilastatin Impurity H |
|
|
![(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol)](/) |
(trans, trans)-3,3'-(1,4,7,10-tetraazacyclododecane-1,7-diyl)bis(butane-1,2,4-triol) |
|
|
![Azelastine Impurity K](/) |
Azelastine Impurity K |
|
|
![(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1-](/) |
(4R,6R)-6-(2-((1S,2S)-2,6-dimethyl-1,2,3,4-tetrahydronaphthalen-1- |
|
|
![Carbazochrome Sodium Sulfonate Impurity 1](/) |
Carbazochrome Sodium Sulfonate Impurity 1 |
|
|
![Rosuvastatin Impurity 147](/) |
Rosuvastatin Impurity 147 |
|
|
![NA](/) |
NA |
|
|
![Cetrorelix Impurity 10](/) |
Cetrorelix Impurity 10 |
|
|
![Cetrorelix Impurity 3 (9-D-Pro)](/) |
Cetrorelix Impurity 3 (9-D-Pro) |
|
|
![Peramivir Intermediate Impurity 42](/) |
Peramivir Intermediate Impurity 42 |
|
|
![Nintedanib impurity A drops](/) |
Nintedanib impurity A drops |
|
|
![Tofacitinib impurity N drops](/) |
Tofacitinib impurity N drops |
|
|
![Carboprost impurity 999](/) |
Carboprost impurity 999 |
|
|
![Bumetanide impurity C drops](/) |
Bumetanide impurity C drops |
|
|
![Troxipide Impurity 6](/) |
Troxipide Impurity 6 |
|
|
![Piperacillin Impurity K](/) |
Piperacillin Impurity K |
|
|
![2-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzoic acid](/) |
2-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzoic acid |
|
|
![3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester](/CAS/20210305/GIF/2591260-03-4.gif) |
3-Thiophenecarboxylic acid, 4-methyl-5-(4-nitrophenyl)-2-[(propoxycarbonyl)amino]-, ethyl ester |
2591260-03-4 |
C18H20N2O6S |
![Pemetrexed disodium Impurity 32](/) |
Pemetrexed disodium Impurity 32 |
|
|
![Androsta-1,4-diene-17-carboxylic acid, 11,16,17-trihydroxy-3-oxo-, (11β,16α,17α)-](/CAS/20210305/GIF/1185143-75-2.gif) |
Androsta-1,4-diene-17-carboxylic acid, 11,16,17-trihydroxy-3-oxo-, (11β,16α,17α)- |
1185143-75-2 |
C20H26O6 |
![Tazobactam Impurity LTE](/) |
Tazobactam Impurity LTE |
|
|
![Isavuconazole Impurity 47](/) |
Isavuconazole Impurity 47 |
|
|
![5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one)](/CAS/20211123/GIF/753498-27-0.gif) |
5,5'-((1R,1'R)-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)azanediyl)bis(1-hydroxyethane-2,1-diyl))bis(8-(benzyloxy)quinolin-2(1H)-one) |
753498-27-0 |
C49H49N3O6 |
![2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid](/) |
2-((6S,8S,9S,10R,11S,13S,14S,17S)-11-hydroxy-6,10,13-trimethyl-3-oxo- 6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoacetic acid |
|
|
![Eltrombopag Impurity 37](/CAS/20210305/GIF/350024-70-3.gif) |
Eltrombopag Impurity 37 |
350024-70-3 |
C14H18N2O |
![2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropan-1-ol](/CAS/20181212/GIF/CB09996368.gif) |
2-(4-(2-(4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropan-1-ol |
|
C28H39N3O2 |
![Tafluprost Impurity 20](/) |
Tafluprost Impurity 20 |
|
|
![Rosuvastatin Impurity 149](/) |
Rosuvastatin Impurity 149 |
|
|
![2-CHLOROMETHYL-5-TRIFLUOROMETHYL-[1,3,4]OXADIAZOLE](/CAS/GIF/723286-98-4.gif) |
2-CHLOROMETHYL-5-TRIFLUOROMETHYL-[1,3,4]OXADIAZOLE |
723286-98-4 |
C4H2ClF3N2O |
![Rifampicin Quinone Oxide](/) |
Rifampicin Quinone Oxide |
|
|
![1-(2-(4-(((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)amino)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate](/) |
1-(2-(4-(((2-(4-(([1,1'-biphenyl]-2-ylcarbamoyl)oxy)piperidin-1-yl)ethyl)(methyl)amino)methyl)-N-methylbenzamido)ethyl)piperidin-4-yl [1,1'-biphenyl]-2-ylcarbamate |
|
|
![1-Phenyl-3,4-dihydroisoquinoline](/CAS/GIF/52250-50-7.gif) |
1-Phenyl-3,4-dihydroisoquinoline |
52250-50-7 |
C15H13N |
![Pyrazinecarboxamide, 3,6-difluoro- (9CI)](/CAS/GIF/356783-29-4.gif) |
Pyrazinecarboxamide, 3,6-difluoro- (9CI) |
356783-29-4 |
C5H3F2N3O |
![Benzamide, 3-hydrazino- (9CI)](/CAS/GIF/473927-51-4.gif) |
Benzamide, 3-hydrazino- (9CI) |
473927-51-4 |
C7H9N3O |
![4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H benzimidazol-2-yl]butanoic acid](/CAS/20211123/GIF/1926162-37-9.gif) |
4-[5-({2-[(4-{5-[Bis(2-chloroethyl)amino]-1-methyl-1H-benzimidazol-2-yl}butanoyl)oxy]ethyl}(2-chloroethyl)amino)-1-methyl-1H benzimidazol-2-yl]butanoic acid |
1926162-37-9 |
C32H42Cl4N6O4 |
![Isavuconazole Impurity 39](/CAS/20240320/GIF/207224-73-5.gif) |
Isavuconazole Impurity 39 |
207224-73-5 |
C21H18F2N4OS |
![Isavuconazole Impurityi45](/) |
Isavuconazole Impurityi45 |
|
|
![Gatifloxacinacid](/CAS/GIF/121577-32-0.gif) |
Gatifloxacinacid |
121577-32-0 |
C19H22FN3O4.ClH |
![Bisoprolol Impurity 41](/) |
Bisoprolol Impurity 41 |
|
|
![1,4-Naphthalenedione, 2-(3-hydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraenyl)-3-methyl-, (,E,E)- (9CI)](/CAS/20211123/GIF/65061-22-5.gif) |
1,4-Naphthalenedione, 2-(3-hydroxy-3,7,11,15-tetramethyl-1,6,10,14-hexadecatetraenyl)-3-methyl-, (,E,E)- (9CI) |
65061-22-5 |
C31H40O3 |
![Piperacilin](/) |
Piperacilin |
|
|
![Varenicline Impurity D](/) |
Varenicline Impurity D |
|
|
![2-Propanone, 1-(2-hydroxypropoxy)- (9CI)](/CAS/GIF/90817-38-2.gif) |
2-Propanone, 1-(2-hydroxypropoxy)- (9CI) |
90817-38-2 |
C6H12O3 |
![Nirmatrelvir Impurity 4](/) |
Nirmatrelvir Impurity 4 |
|
|
![Nifedipine Impurity L](/) |
Nifedipine Impurity L |
|
|
![2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI)](/CAS/GIF/155102-96-8.gif) |
2-Pyrrolidinone, 3,4-dihydroxy-5-(hydroxymethyl)-, (3R,4R,5R)- (9CI) |
155102-96-8 |
C5H9NO4 |
![Bumetanide Impurity 24](/) |
Bumetanide Impurity 24 |
|
|
![Rocuronium Bromide Impurity 37、38、39](/) |
Rocuronium Bromide Impurity 37、38、39 |
|
|
![Ritonavir EP Impurity HIJ](/) |
Ritonavir EP Impurity HIJ |
|
|
![Crisaborole Impurity 42](/) |
Crisaborole Impurity 42 |
|
|
![Perospirone Impurity 26](/) |
Perospirone Impurity 26 |
|
|
![Paxlovid Impurity 15](/) |
Paxlovid Impurity 15 |
|
|
![3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide](/) |
3-(2-(cyclopent-2-en-1-yl)-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium bromide |
|
|
![Canagliflozin Impurity 84](/) |
Canagliflozin Impurity 84 |
|
|
![Fondaparinux sodium impurity 18](/) |
Fondaparinux sodium impurity 18 |
|
|